←Geriatrics & Peri-op
Pre-operative cardiac risk
📚
📚 Library › 👵 Geriatrics & Peri-op › Peri-operative
🔪

Pre-operative cardiac risk

The 2024 ACC/AHA stepwise approach — RCRI, functional capacity, BNP, what to hold and when.

preopRCRIMETsBNPperioperative
🗓️ Reviewed 2026-11-18 · ⏱️ 3 min read · 📖 2024 ACC/AHA/multisociety perioperative cardiovascular guideline · PAUSE · BRIDGE
🧠 Pathophysiology in 60 seconds🔎 Risk tools💊 Medication plan✍️ How to write the note🎓 Board corner📚 References
⚡ Bottom line — first hour
  • Emergency surgery → go. Optimize on the way; do not delay for testing.
  • Active cardiac condition (ACS, decompensated HF, severe valve disease, unstable arrhythmia) → fix it first.
  • Low risk (RCRI 0–1 / <1% MACE) → proceed.
  • Elevated risk + good functional capacity (≥4 METs, e.g., 2 flights of stairs) → proceed.
  • Elevated risk + poor/unknown capacity → BNP/NT-proBNP (2024) → stress test only if it would change management anyway.
  • "Cardiac clearance" does not exist — write risk + recommendations.

🧠 Pathophysiology in 60 seconds

⌄
  • Surgery = stress test: catecholamines, bleeding, hypotension, hypercoagulability, anemia, pain.
  • Most perioperative MIs are type 2 (supply–demand), silent, and found only with troponin → MINS (myocardial injury after non-cardiac surgery) predicts 30-day death.
  • Pre-op revascularization of stable CAD does not reduce risk (CARP).

🔎 Risk tools

⌄
RCRI (1 point each)
High-risk surgery (intraperitoneal, intrathoracic, suprainguinal vascular)
Ischemic heart disease
Heart failure
Cerebrovascular disease
Insulin-treated diabetes
Creatinine >2.0 mg/dL

0 → ~4% · 1 → ~6% · 2 → ~10% · ≥3 → ~15% (MACE in modern cohorts). Alternatives: NSQIP calculator, Gupta MICA.

  • ≥4 METs (2 flights of stairs, brisk walk 4 mph, heavy housework) = adequate. DASI score >34 more objective.
  • BNP ≥92 pg/mL or NT-proBNP ≥300 → higher risk → consider post-op troponin surveillance.
  • ECG: elevated-risk surgery with known heart disease. TTE: unexplained dyspnea, murmur, HF change.

💊 Medication plan

⌄
Drug Plan
β-blocker Continue if chronic. Do not start on the day of surgery (POISE).
Statin Continue; start if indicated
ACEi/ARB Continue or hold 24 h — individualize (hold if hypotension risk); restart early
SGLT2 inhibitor Hold 3 days (ertugliflozin 4 days) — euglycemic DKA
Aspirin (secondary prevention) Continue for most; hold for closed-space surgery (spine, intracranial, posterior eye)
Aspirin (primary prevention) Hold 7 days
P2Y12 with recent stent Delay elective surgery: ≥6 months after DES (≥3 months if surgery delay is harmful); 12 months after ACS ideally. Keep aspirin.
Drug Low/moderate bleed risk High bleed risk
Apixaban / rivaroxaban / edoxaban Hold 1 day Hold 2 days
Dabigatran (CrCl ≥50) 1 day 2 days
Dabigatran (CrCl <50) 2 days 4 days
Warfarin Hold 5 days, INR day before Same
  • No bridging for AF (BRIDGE). Bridge only selected: mechanical mitral valve, recent (<3 months) VTE/stroke, very high thrombotic risk.
  • Restart DOAC 24 h after low-risk, 48–72 h after high-risk surgery.
  • Basal insulin: give 75–80% night before / morning of surgery.
  • GLP-1 RA: most continue; for high-aspiration-risk patients, liquid diet 24 h before (2024 multisociety guidance).
  • Stress-dose steroids if chronic steroid user (see adrenal page).

✍️ How to write the note

⌄

"Patient is at elevated risk (RCRI 2: insulin-treated DM, Cr 2.3) for intermediate-risk surgery. Functional capacity ≥4 METs. No active cardiac conditions. No further testing will change management. Recommend: continue metoprolol and atorvastatin, hold empagliflozin 3 days prior, post-op troponin ×2 given elevated BNP."

🎓 Board corner

⌄
Stem Answer
Elevated risk, climbs 3 flights Proceed without testing
Stable CAD, abnormal stress test, elective hip Revascularization does not reduce periop risk — proceed with medical therapy
DES 2 months ago, elective cholecystectomy Delay if possible (≥6 months)
AF on apixaban, low-bleed surgery Hold 1 day, no bridge
Start metoprolol morning of surgery? No (POISE: stroke, death)

📚 References

⌄
  • Thompson A, et al. 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery. Circulation. 2024;150:e351.
  • Douketis JD, et al. PAUSE. JAMA Intern Med. 2019 · BRIDGE. NEJM. 2015.
  • POISE (Lancet 2008) · CARP (NEJM 2004) · VISION.
↩︎ Back to 👵 Geriatrics & Peri-op